Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atripla 600mg/200mg/245mg tablets
0503010ANBBAAAA
|
Atripla | Efavirenz/emtricitabine/tenofovir disoproxil | Infections | 5 |
|
Atropine 3mg/10ml solution for injection pre-filled syringes
1501030D0AABDBD
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | 5 |
|
Aymes Actagain 2.0 Fibre Starter Pack liquid
0913011U0BDABAD
|
Aymes Rts 2 kcal/ml m/sk high protein, high energy+fibre | RtS 2 kcal/ml m/sk high protein, high energy+fibre (0913011) | Nutrition and Blood | 5 |
|
Aymes Actasolve Shake Fibre Starter Pack powder
0913011D0BBAAAC
|
Aymes powder 1.6 kcal/ml milkshake with fibre | Powder 1.4 - 1.6 kcal/ml milkshake with fibre (0913011) | Nutrition and Blood | 5 |
|
Beclometasone 200micrograms/dose inhaler
0302000C0AAARAR
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 5 |
|
Bedranol 10mg tablets
0204000R0BDAGAH
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 5 |
|
Benzocaine 5mg / Tyrothricin 1mg lozenges
1203030B0AAACAC
|
Benzocaine (Antiseptic lozenge/spray) | Benzocaine | Ear, Nose and Oropharynx | 5 |
|
Benzoic acid compound ointment
1310020D0AAAAAA
|
Benzoic acid co | Benzoic acid | Skin | 5 |
|
Benzoin compound tincture
0308000B0AAAAAA
|
Benz | Benzoin | Respiratory System | 5 |
|
Betahistine 8mg/5ml oral solution
0406000B0AAADAD
|
Betahistine hydrochloride | Betahistine hydrochloride | Central Nervous System | 5 |
|
Biosorb Gelling Fibre dressing 10cm x 10cm square
20031700254
|
Biosorb Gelling Fibre dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 5 |
|
Bioteque America ring pessary size 1, 51mm diameter, silicone with support
21011200332
|
Bioteque America ring pessary size 1, 51mm diameter, silicone with support | Other Appliances | Appliances | 5 |
|
Biotrol Softima colostomy bag with filter beige 45mm
23350453672
|
Biotrol Softima colostomy bag with filter beige 45mm | Colostomy Bags | Stoma Appliances | 5 |
|
Birkbeck rubber ileostomy night bag 19mm black
23601256218
|
Birkbeck rubber ileostomy night bag 19mm black | Ileostomy Bags | Stoma Appliances | 5 |
|
BLUselect tracheostomy tube inner cannula 73mm length
20050600236
|
BLUselect tracheostomy tube inner cannula 73mm length | Tracheostomy & Laryngectomy Appliances | Dressings | 5 |
|
BLUselect tracheostomy tube Soft-Seal cuff Suctionaid 73mm length
20050600195
|
BLUselect tracheostomy tube Soft-Seal cuff Suctionaid 73mm length | Tracheostomy & Laryngectomy Appliances | Dressings | 5 |
|
C-Foam Silicone Border dressing 10cm x 20cm
20030900332
|
C-Foam Silicone Border dressing 10cm x 20cm | Wound Management & Other Dressings | Dressings | 5 |
|
C1-esterase inhibitor 500unit inj vials
0304030F0AAAAAA
|
C1-Esterase inhibitor | C1-Esterase inhibitor | Respiratory System | 5 |
|
Calcium carbonate 400mg capsules
0101021C0AABQBQ
|
Calcium carbonate (Antacid) | Calcium carbonate | Gastro-Intestinal System | 5 |
|
Calpol Infant 120mg/5ml susp 5ml sachets sugar free
0407010H0BEADAJ
|
Calpol | Paracetamol | Central Nervous System | 5 |
|
Camcolit 250 tablets
0402030K0BBAAAC
|
Camcolit | Lithium carbonate | Central Nervous System | 5 |
|
Captopril 3mg/5ml oral liquid
0205051F0AACDCD
|
Captopril | Captopril | Cardiovascular System | 5 |
|
Carbagen SR 200mg tablets
0408010C0BFAAAG
|
Carbagen | Carbamazepine | Central Nervous System | 5 |
|
Carbamazepine 200mg/5ml oral liquid
0408010C0AAAXAX
|
Carbamazepine | Carbamazepine | Central Nervous System | 5 |
|
Cardioace tablets
091000000BBXZBU
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | 5 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.